Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study. Stein EM, DiNardo CD, Fathi AT, Mims AS, et al. Blood 2021;137:1792-1803.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stein EM, DiNardo CD, Fathi AT, Mims AS, et al. Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study. Blood 2021;137:1792-1803.
PMID: 33024987